FFT Wealth Management LLC Has $361,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

FFT Wealth Management LLC lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 24.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 811 shares of the medical equipment provider’s stock after selling 266 shares during the quarter. FFT Wealth Management LLC’s holdings in Intuitive Surgical were worth $361,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. grew its position in Intuitive Surgical by 1.6% during the first quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock worth $12,319,358,000 after buying an additional 493,126 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in Intuitive Surgical by 1.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 16,973,266 shares of the medical equipment provider’s stock worth $5,726,102,000 after buying an additional 272,741 shares in the last quarter. Capital World Investors grew its position in Intuitive Surgical by 1.0% during the first quarter. Capital World Investors now owns 7,284,269 shares of the medical equipment provider’s stock worth $2,907,079,000 after buying an additional 73,634 shares in the last quarter. Edgewood Management LLC grew its position in Intuitive Surgical by 7.9% during the fourth quarter. Edgewood Management LLC now owns 5,131,066 shares of the medical equipment provider’s stock worth $1,731,016,000 after buying an additional 374,667 shares in the last quarter. Finally, Jennison Associates LLC grew its position in Intuitive Surgical by 4.6% during the first quarter. Jennison Associates LLC now owns 4,488,343 shares of the medical equipment provider’s stock worth $1,791,253,000 after buying an additional 198,483 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In other news, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction dated Wednesday, June 5th. The stock was sold at an average price of $411.00, for a total value of $575,400.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, EVP Robert Desantis sold 239 shares of the firm’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $416.60, for a total value of $99,567.40. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,293,799.60. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $411.00, for a total transaction of $575,400.00. The disclosure for this sale can be found here. Insiders sold a total of 53,056 shares of company stock worth $25,276,044 in the last three months. Company insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of analyst reports. JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $475.00 to $495.00 and gave the stock an “overweight” rating in a research report on Friday, July 19th. Stifel Nicolaus upped their target price on Intuitive Surgical from $430.00 to $475.00 and gave the stock a “buy” rating in a research note on Friday, July 19th. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their target price for the stock from $380.00 to $510.00 in a research note on Friday, August 2nd. Evercore ISI cut their target price on Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating for the company in a research note on Friday, July 19th. Finally, Truist Financial upped their target price on Intuitive Surgical from $450.00 to $515.00 and gave the stock a “buy” rating in a research note on Tuesday, July 16th. Six research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $446.45.

Intuitive Surgical Price Performance

Shares of ISRG opened at $492.63 on Monday. The stock has a 50-day moving average of $454.69 and a 200-day moving average of $414.94. The company has a market cap of $175.06 billion, a PE ratio of 88.92, a P/E/G ratio of 5.43 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $493.97.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, beating the consensus estimate of $1.54 by $0.24. The company had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The firm’s revenue for the quarter was up 14.5% compared to the same quarter last year. During the same period last year, the business posted $1.18 EPS. Analysts expect that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.